Project 3: Contribution of Small Airways to Cystic Fibrosis Lung Disease Pathogenesis
Project 3: Contribution of Small Airways to Cystic Fibrosis Lung Disease Pathogenesis
批准号:
10226940
负责人:
Joseph Zabner
金额:
$35.69万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-09-05 至 2023-06-30
关键词:
ATP12A geneAffectAirAirway DiseaseApicalCartilageClinicalCystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorDataDefectDiseaseEpithelialEpithelial CellsFamily suidaeFeedbackGene Expression ProfileGlandHost DefenseImmuneImpairmentInflammationKnowledgeLungLung diseasesMorphologyMucociliary ClearanceMucous body substanceNatural ImmunityNewborn InfantPathogenesisPhysiologyPlayProtein IsoformsProton-Translocating ATPasesProtonsPulmonary Cystic FibrosisRegulationRoleSurfaceViral Respiratory Tract InfectionVirusadeno-associated viral vectorairway epitheliumairway surface liquidantimicrobialbasecell typecystic fibrosis airwayearly cystic fibrosisintervention effectnovelpreventrestorationselective expressionvacuolar H+-ATPasevector
中文摘要
项目3
摘要
通常认为,慢性阻塞性肺疾病始于小气道。而一个数字
的观察表明这一假设是正确的,我们没有直接的实验
证据。因为我们对大型CF中的主机防御缺陷有更多的了解
我们可以推测,小的CF航空公司的异常也是一样的。
然而,上皮形态、细胞类型和黏膜下缺乏的差异
腺体和连续的软骨表明,小气道并不是简单的“小”。
大型航空公司。对于详细的信息,较小的航空公司相对难以进入
机械学研究。因此,我们对许多关键问题缺乏答案。是什么
慢性阻塞性肺疾病小气道表面液体pH它是如何控制的?什么
将质子分泌到小气道的机制?粘液纤毛运输是否受到干扰
小型航空公司?ASL抗菌剂的活性是否受损?CFTR是否存在于小型呼吸道
足以预防慢性肺病吗?随着慢性肺病的进展,宿主如何
小呼吸道的防御和疾病发生了变化?我们最重要的假设是
小气道中CFTR的缺乏是CF肺疾病发病的关键。
我们将调查3个具体目标:
具体目的1.小气道缺乏CFTR是否会导致宿主防御缺陷?
根据我们的初步数据,我们假设新生儿CF小气道将是
酸性更强,对宿主的防御能力会有损害。
特定目的2.V-ATPase是否在调节小气道表面中起作用
液体酸碱度?我们假设V-ATPase表达于
小气道上皮细胞的特定细胞类型及其在反馈中的作用
调节ASL pH的机制。
特定目的3.CFTR在小气道中的表达是否会阻止CF猪肺
疾病?我们将使用一种新型的AAV载体在小鼠中选择性地表达CFTR
CF型猪的呼吸道上皮细胞。我们将调查CFTR修复的效果
对早期肺部表现的作用。
对这些问题的回答,将指导该领域理解
在小呼吸道疾病和确定更好的治疗CF的策略方面。
英文摘要
PROJECT 3
ABSTRACT
It is often assumed that CF lung disease begins in the small airways. While a number
of observations suggest this assumption is correct, we do not have direct experimental
evidence. Because we have more knowledge of host defense defects in large CF
airways, we might conjecture that the abnormalities in small CF airways are the same.
However, differences in epithelial morphology, cell types, and lack of submucosal
glands and continuous cartilages suggest that small airways are not simply “small”
large airways. The small airways have been relatively inaccessible for detailed
mechanistic studies. As a result, we lack answers to many key questions. What is
the airway surface liquid pH in CF small airways? How is it controlled? What
mechanism secretes protons into small airways? Is mucociliary transport disrupted in
small airways? Is the activity of ASL antimicrobials impaired? Is CFTR in small airways
sufficient to prevent CF lung disease? As CF lung disease progresses how do host
defenses and disease in small airways change? Our overarching hypothesis is that
lack of CFTR in the small airway is pivotal for the pathogenesis of CF lung disease.
We will investigate 3 specific aims:
Specific Aim 1. Does lack of CFTR in small airways result in host defense defects?
Based on our preliminary data we hypothesize that newborn CF small airways will be
more acidic, and will have an impairment in host defenses.
Specific Aim 2. Does V-ATPase play a role in regulating small airways airway surface
liquid pH? We hypothesize that V-ATPase is expressed on the apical surface of a
specific cell type of small airway epithelial cells and plays a role in a feedback
mechanism that regulates ASL pH.
Specific Aim 3. Will CFTR expression in small airways of prevent CF pig lung
disease? We will use a novel AAV vector to selectively express CFTR in the small
airway epithelial cells of CF pigs. We will investigate the effect of restoration of CFTR
function on manifestations of early lung.
Answers to these questions, will guide the field in understanding the contribution of
small airways to disease and in identifying strategies for better treatments of CF.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
In Vitro Models and Cell Culture Core
-
批准号:10470333
-
项目类别:
-
资助金额:$18.54万
-
财政年份:2020
-
负责人:Joseph Zabner
-
依托单位:
In Vitro Models and Cell Culture Core
-
批准号:10248525
-
项目类别:
-
资助金额:$18.54万
-
财政年份:2020
-
负责人:Joseph Zabner
-
依托单位:
In Vitro Models and Cell Culture Core
-
批准号:10024663
-
项目类别:
-
资助金额:$18.54万
-
财政年份:2020
-
负责人:Joseph Zabner
-
依托单位:
In Vitro Models and Cell Culture Core
-
批准号:10677585
-
项目类别:
-
资助金额:$18.54万
-
财政年份:2020
-
负责人:Joseph Zabner
-
依托单位:
Ancillary Study 1
-
批准号:7934327
-
项目类别:
-
资助金额:$120.54万
-
财政年份:2010
-
负责人:Joseph Zabner
-
依托单位:
Directed evolutioni of AAV for gene theraphy in a pig model of cystic fibrosis
-
批准号:7741474
-
项目类别:
-
资助金额:$28.86万
-
财政年份:2009
-
负责人:Joseph Zabner
-
依托单位:
Cell Culture Core
-
批准号:7741487
-
项目类别:
-
资助金额:$28.86万
-
财政年份:2009
-
负责人:Joseph Zabner
-
依托单位:
Request for Funds to Purchase a Replacement Laser Scanning Confocal Microscope
-
批准号:7591586
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2009
-
负责人:Joseph Zabner
-
依托单位:
Project 3: Contribution of Small Airways to Cystic Fibrosis Lung Disease Pathogenesis
-
批准号:10470212
-
项目类别:
-
资助金额:$35.69万
-
财政年份:2008
-
负责人:Joseph Zabner
-
依托单位:
Early airway infection in a porcne model of cystic fibrosis
-
批准号:7486390
-
项目类别:
-
资助金额:$28.81万
-
财政年份:2008
-
负责人:Joseph Zabner
-
依托单位:
Cells and Tissue Core
-
批准号:7688345
-
项目类别:
-
资助金额:$16.88万
-
财政年份:2008
-
负责人:Joseph Zabner
-
依托单位:
in Vitro Models and Cell Culture Core
-
批准号:7486395
-
项目类别:
-
资助金额:$7.51万
-
财政年份:2008
-
负责人:Joseph Zabner
-
依托单位:
SAFETY OF AEROSOLIZED XYLITOL IN SUBJECTS WITH CYSTIC FIBROSIS
-
批准号:7377064
-
项目类别:
-
资助金额:$0.23万
-
财政年份:2006
-
负责人:Joseph Zabner
-
依托单位:
BRONCHOSCOPIC ASSESSMENT OF AIRWAY RETENTION TIME OF AEROSOLIZED XYLITOL
-
批准号:7201351
-
项目类别:
-
资助金额:$0.52万
-
财政年份:2005
-
负责人:Joseph Zabner
-
依托单位:
Ligand-Receptor Segregation and Airway Remodeling
-
批准号:6822837
-
项目类别:
-
资助金额:$33.19万
-
财政年份:2004
-
负责人:Joseph Zabner
-
依托单位:
Ligand-Receptor Segregation and Airway Remodeling
-
批准号:6942288
-
项目类别:
-
资助金额:$33.19万
-
财政年份:2004
-
负责人:Joseph Zabner
-
依托单位:
Core-- Administration
-
批准号:6853157
-
项目类别:
-
资助金额:$7.25万
-
财政年份:2004
-
负责人:Joseph Zabner
-
依托单位:
Interactions of AAV5 with Sialic Acid and PDGF Receptors
-
批准号:6853149
-
项目类别:
-
资助金额:$19.5万
-
财政年份:2004
-
负责人:Joseph Zabner
-
依托单位:
Ligand-Receptor Segregation and Airway Remodeling
-
批准号:7104251
-
项目类别:
-
资助金额:$32.41万
-
财政年份:2004
-
负责人:Joseph Zabner
-
依托单位:
Effect of Ionic Versus Non-Ionic Osmolytes in the Airway
-
批准号:7040797
-
项目类别:
-
资助金额:$0.34万
-
财政年份:2004
-
负责人:Joseph Zabner
-
依托单位:
海外基金